Search
Zoetis Inc
ZTSAdd to Watchlist
71.400USD
-1.620-2.22%
Close 09-18 16:00（ET）
29.59BMarket Cap
11.83P/E TTM
After-hours 19:00 (ET)71.400USD-0.140-0.20%
After-hours 19:00 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.22%
5 Days
-2.15%
1 Month
-3.46%
6 Months
-38.47%
Year to Date
-42.36%
1 Year
-50.53%
Key Figures
72.565Open
73.050High
1.31MVolume
11.83P/E TTM
11.27P/E Dynamic
2.060Dividend TTM
0.32%Turnover Ratio
73.020Prev. Close
71.400Low
94.94MTurnover
11.90P/E Static
9.40P/B
2.88%Div Yield TTM
18.07%ROA
145.98652wk High
117.91Volume Ratio
2.49BNet Profit
414.15MShares
6.0419EPS TTM
0.77Beta
67.01%ROE
71.00052wk Low
2.19%Amplitude
71.64%Gross Margin
29.59BMarket Cap
-1.95Reward/Risk
2.38%Risk Rate
Recent
Earnings
Novo Nordisk A/S Stock (NVO) Closed Up by 3.11% on Aug 6: What Investors Need To Know
• Novo Nordisk raised full-year sales and operating profit guidance amid strong metabolic drug demand. • Clinical data shows efficacy for cardiovascular and kidney diseases, expanding the potential patient base. • Current technical indicators show a neutral MACD signal and oversold Williams %R conditions.
TradingKeyThu, Aug 6
Insmed Inc Stock (INSM) Moved Up by 31.83% on Aug 6: Key Drivers Unveiled
• Insmed shares rose following positive clinical trial data and potential acquisition interest. • Analysts revised revenue models, setting an average price target of $196.74. • Technical indicators show a sell signal with the stock currently in oversold territory.
TradingKeyThu, Aug 6
Zoetis Inc's Score
0.08vs previous score
Forecast7.40
Financial Health8.59
Technical3.11
Valuation Dimensions9.10
Institutional Confidence10.00
Risk Assessment6.59
Media Coverage
Coverage Level
17°C
Very Low
Very High
Neutral
Analyst Rating
Zoetis Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
1.65/1.86
Revenue / Forecast
2.47B/2.50B
Zoetis Inc Profile
SectorPharmaceuticals
Ticker SymbolZTS
Number of employees13800
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.22% |
| Vanguard Portfolio Management, LLC | 5.72% |
| BlackRock Institutional Trust Company, N.A. | 5.67% |
| State Street Investment Management (US) | 4.72% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 52.29% |
| Investment Advisor/Hedge Fund | 33.37% |
| Research Firm | 4.25% |
| Insurance Company | 4.11% |
Related Instruments
+0.04%
-0.09%
-0.04%
-0.02%
-0.19%
-0.39%
+1.55%
-0.52%
+0.07%
+0.12%
+0.35%
-1.55%
-1.65%
-1.53%
-0.56%
-0.58%
-0.55%
-2.55%
-0.73%
-0.42%Popular Instruments
51734.000
-26.000 (-0.05%)
29664.700
+252.000 (+0.86%)
7659.100
+27.000 (+0.35%)
14420.000
+119.000 (+0.83%)
65079.000
+130.000 (+0.20%)
6230.800
-76.400 (-1.21%)
96.001
-1.985 (-2.03%)
336.130
-0.870 (-0.26%)
222.270
+2.930 (+1.34%)
4377.330
+36.350 (+0.84%)
FAQs
What is the current price of Zoetis Inc (ZTS)?
The current price of Zoetis Inc (ZTS) is 71.40.
What is the symbol of Zoetis Inc?
The ticker symbol of Zoetis Inc is ZTS.
What is the 52-week high of Zoetis Inc?
The 52-week high of Zoetis Inc is 145.99.
What is the 52-week low of Zoetis Inc?
The 52-week low of Zoetis Inc is 71.00.
What is the market capitalization of Zoetis Inc?
The market capitalization of Zoetis Inc is 29.59B.
Is Zoetis Inc (ZTS) currently rated as Buy, Hold, or Sell?
According to analysts, Zoetis Inc (ZTS) has an overall rating of Buy, with a price target of 99.08.
What is the Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS)?
The Earnings Per Share (EPS TTM) of Zoetis Inc (ZTS) is 6.04.